Repligen (RGEN) Tops Q2 EPS by 27c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
July 27, 2021 7:30 AM EDTReported revenue was $163.0 million for the quarter, representing year-over-year growth of 86% and organic growth of 69%Revenue guidance raised to $625-$645 million for full year 2021Acquisition of hollow fiber innovator Polymem S.A. completed July 1, 2021
WALTHAM, Mass., July 27, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its second quarter of 2021. Provided in this press release are financial highlights for the three- and six- month periods ended June 30, 2021,... More
